BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.7...

... Cure. "I join with Dr. Irving in thanking the OCS for their generous support in acclerating pluripotent stem cell research into clinical applications," said Benjamin Reubinoff, MD, PhD, Chief Scientific Officer of Cell Cure and Chairman of ...

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131223005171&newsLang=en&ndmConfigId=1000639&vnsId=41